Pay in 4 interest-free payments of $50.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Obesity and weight management models
diagnostic procedures
Form: Lyophilized powder (2mg or 5mg sterile vial)
Retatrutide is rapidly becoming a leading candidate in obesity and metabolic disorder research—demonstrating superior results to Semaglutide and Tirzepatide in early trials
Retatrutide mg:5mg x 10 vials Obesity and weight management modelsRetatrutide Peptide Triple Agonist (GLP 1 GIP Glucagon) Ultra Pure 99% for Advanced Fat Loss & Metabolic Research Welcome to the next generation of peptide science. Retatrutide is a revolutionary triple agonist targeting GLP 1, GIP, and Glucagon receptorsdelivering unmatched potential in fat loss, energy regulation, and metabolic health. Now available in ultra pure 99% pharmaceutical grade form for high performance research and experimental protocols.